ArticleBlood2024

HA-1-targeted T-cell receptor T-cell therapy for recurrent leukemia after hematopoietic stem cell transplantation.

Elizabeth F Krakow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.